The Chart Show: Ashtead, Polymetal, Moderna

TL;DR

Ashsted is the top performer on the FTSE 100, benefiting from the global economic reopening post-2020. Poly Metal, a precious metals miner, has suffered heavy losses due to investors moving towards riskier investments. Moderna, with its successful COVID vaccine rollout, has sharply outperformed the US market.

Transcript

hello and welcome to the chart show i'm victoria scholar each week i'll be sharing my analysis on three key stories that are getting a lot of attention among investors breaking them down not just from a fundamental perspective but with technical analysis on the charts as well this week is the last chart show of the year so let's take a look back at... Read More

Key Insights

• 🎭 Ashted has been the best-performing stock on the FTSE 350 in the last decade, showcasing consistent growth.
• 🤘 Poly Metal's underperformance is attributed to investors' preference for riskier assets and the decline in precious metals.
• 📈 Moderna's share price growth has slowed down after a significant rally, but the upward trend line remains intact.
• 🌐 Ashted's future performance may depend on the state of the global economy and its recovery from the pandemic.
• 🦺 Poly Metal's potential upswing relies on safe haven demand resurgence and inflationary concerns.
• 🧑‍🏭 Factors like vaccine effectiveness and commercialization greatly impact Moderna's performance.
• 📈 Ashsted's long-term chart shows an ascending trend line, indicating continued bullishness.

Questions & Answers

Q: Why has Ashted been the top performer on the FTSE 100?

Ashted has benefited from the global economic reopening and its performance is closely tied to the economy, making it a key beneficiary of the return to normality after the COVID slump.

Q: Why has Poly Metal underperformed in 2021?

Poly Metal has suffered heavy losses due to investors favoring riskier investments like tech stocks and Bitcoin over safe haven assets. The decline in the precious metals complex has also contributed to its underperformance.

Q: Will Poly Metal see an upswing in 2022?

The potential for a safe haven demand resurgence, especially if concerns about inflation grow, could drive Poly Metal higher. However, the stock's downtrend continues, and a fresh low below 12.24 could lead to further declines.

Q: What has contributed to Moderna's outperformance in 2021?

Moderna's successful rollout of its COVID vaccine, which generated significant revenues, has led to its sharp outperformance in the US market. The approval and commercialization of the vaccine have been key factors.

Summary & Key Takeaways

• Ashted reported a record performance, benefiting from the global economic reopening and outperforming the broader market.

• Poly Metal has underperformed due to investors moving away from safe haven assets, but it might see a potential upswing if inflation concerns grow.

• Moderna has experienced significant share price growth with its successful COVID vaccine rollout, but it has recently faced a pullback.